Drug development
-
Business & Markets · Startups Dash Bio Secures $11 Million for Automated Bioanalysis and Drug Discovery
Insider Brief PRESS RELEASE — Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has raised an additional $11 million in funding, bringing its… -
Policy & Government · Regulation Enveric Biosciences Opens Bidding Process for PsyAI™ Trademark Portfolio Amid Focus on Drug Development
-
Business & Markets · Startups Archon Biosciences Launches with $20M Seed Funding to Boost Drug Development Using AI-Driven ‘Antibody Cages’
-
Business & Markets · Startups Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development
-
Business & Markets · Startups Formation Bio Secures $372M Series D Funding to Grow Drug Pipeline and Continue Expanding AI-driven Drug Development Platform
-
Business & Markets · Enterprise Sanofi Strikes New Partnership with OpenAI to Accelerate Drug Development
-
Business & Markets · Startups Cognivia Secures Strategic €15.5M Funding to Empower Drug Development with AI-ML Solutions
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.